Euris avnoteras

Styrelsen har beslutat att lista om bolaget på en annan handelsplats, för att minska kraven på administration.

Stamceller kan stoppa svår MS

Forskare vid Uppsala universitet visar att det är möjligt att stoppa sjukdomen multipel skleros. Genom att behandla patienter med blodstamceller har man lyckats stoppa sjukdomsförloppet.

Finns det grodor så finns det hopp

Forskare har identifierat ett ämne som blockerar det pigment som gör grodyngel fläckiga. På sikt kan rönen leda till bättre behandling av hudcancer.

Major changes to the Q-Med board

The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.

Re-painting the big pig-ture

Why do tame pigs show such variety in colouring, when their wild relatives are so plain? Swedish researchers know who is to blame. But the big question is why.

Teams up with leading dermatologist

Tripep has signed a letter of intent with a major Japanese specialty pharma company to bring their wound healing treatment to a big market.

Orexo opens doors eastwards

The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.

Pfizer lays a chunky bid on Wyeth

The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at approximately $68 billion. The Boards of Directors of both companies have said yes to the deal that may lead to lay-offs of some 8,000 persons.

A smart company takes care of its best

Lundbeck didn't have to look far to find it's new international Director of Marketing. The talent was already in the house.

New CEO to Promedvi

Sigrun Axelsson has taken on the leadership of the Lund-based medtech company.

Almost 150 will leave Coloplast

The Danish medtech company Coloplast negotiates headcount reductions, with a total number of almost 150 employees.

Less scars with new product

A new Swedish product for post surgical scar formation enters clinical development.

Hormones make children fat

A new Danish million project will define the connection between hormons and obesity amongst children.

Medicult needs a word of advice

Medicult Board retains advisers, regarding the previous offer from Vitrolife.

Biovitrum sells UK part

Biovitrum will soon spin-out a British subsidary

Biotech goes white and bright

White biotech could become Denmark's next blossoming business area.

Eli Lilly writes biotech fine history

The American biotech company Eli Lilly will pay US 1.415 billion to resolve allegations of off-label promotion of a dementia drug.

Abbott expands by acquisition

An acquisition gives Abbott a leadership position in another large and growing medical device segment.

Dupont gets new business manager

The Swedish API manufacturer Dupont Chemoswed has appointed a new business development manager.

Swedish multi competent machine soon launched

The Swedish company Biosensor will launch new equipment able to detect twelve different narcotics and explosives simultaneously.

Pharma is a safe market

Pharma is the best industry to invest in. That states leaders from risk capital companies, interviewed by the Economist Intelligence Unit.

LEO Pharma - International Clinical Trial Manager

Ten recieve the Venture Cup West Prize

At this year´s Venture Cup West awards the 10 best business ideas in Venture Cup West 08/09 were chosen, receiving SEK 10 000 each.

Vitrolife wants to acquire Medicult

The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.